Bill Text: FL S1644 | 2024 | Regular Session | Introduced
Bill Title: Student Health
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Failed) 2024-03-08 - Died in Education Pre-K -12 [S1644 Detail]
Download: Florida-2024-S1644-Introduced.html
Florida Senate - 2024 SB 1644 By Senator Powell 24-01286A-24 20241644__ 1 A bill to be entitled 2 An act relating to student health; providing a short 3 title; amending s. 1002.20, F.S.; requiring each 4 district school board to develop and implement a 5 policy for the use of epinephrine auto-injectors; 6 providing requirements for the policy; making 7 technical changes; providing an effective date. 8 9 Be It Enacted by the Legislature of the State of Florida: 10 11 Section 1. This act may be cited as the “Munoz Student 12 Allergy Framework for Emergencies (SAFE) Act.” 13 Section 2. Paragraph (i) of subsection (3) of section 14 1002.20, Florida Statutes, is amended to read: 15 1002.20 K-12 student and parent rights.—Parents of public 16 school students must receive accurate and timely information 17 regarding their child’s academic progress and must be informed 18 of ways they can help their child to succeed in school. K-12 19 students and their parents are afforded numerous statutory 20 rights including, but not limited to, the following: 21 (3) HEALTH ISSUES.— 22 (i) Epinephrine use and supply.— 23 1.a. A student who has experienced or is at risk for life 24 threatening allergic reactions may carry an epinephrine auto 25 injector and self-administer epinephrine by auto-injector while 26 in school, participating in school-sponsored activities, or in 27 transit to or from school or school-sponsored activities if the 28 school has been provided with parental and physician 29 authorization. The State Board of Education, in cooperation with 30 the Department of Health, shall adopt rules for such use of 31 epinephrine auto-injectors that shall include provisions to 32 protect the safety of all students from the misuse or abuse of 33 auto-injectors. 34 b. Each district school board shall develop and implement a 35 policy, in compliance with the rules adopted by the state board 36 and the department, for the use of epinephrine auto-injectors in 37 emergency situations. The policy must include: 38 (I) Procedures for acquiring emergency epinephrine auto 39 injectors and authorizing public schools to acquire emergency 40 epinephrine auto-injectors, which must be maintained in a secure 41 location on a public school’s premises for emergency use. 42 (II) A protocol developed by a licensed physician to train 43 school nurses and school personnel who volunteer to receive such 44 training to identify a person who is suffering from anaphylaxis 45 and administer an epinephrine auto-injection. 46 (III) A procedure for authorizing public schools to 47 designate school personnel to receive initial and annual 48 training. 49 c. A school district, county health department, public 50 private partner, and their employees and volunteers shall be 51 indemnified by the parent of a student authorized to carry an 52 epinephrine auto-injector for any and all liability with respect 53 to the student’s use of an epinephrine auto-injector pursuant to 54 this paragraph. 55 2. A public school may purchase a supply of epinephrine 56 auto-injectors, in compliance with the policy of its district 57 school board in sub-subparagraph 1.b., from a wholesale 58 distributor as defined in s. 499.003 or may enter into an 59 arrangement with a wholesale distributor or manufacturer as 60 defined in s. 499.003 for the epinephrine auto-injectors at 61 fair-market, free, or reduced prices for use in the event a 62 student has an anaphylactic reaction.The epinephrine auto63injectors must be maintained in a secure location on the public64school’s premises. The participating school district shall adopt65a protocol developed by a licensed physician for the66administration by school personnel who are trained to recognize67an anaphylactic reaction and to administer an epinephrine auto68injection.The supply of epinephrine auto-injectors may be 69 provided to and used by a student authorized to self-administer 70 epinephrine by auto-injector under sub-subparagraph 1.a. 71subparagraph 1.or trained school personnel under sub 72 subparagraph 1.b. 73 3. The school district and its employees, agents, and the 74 physician who provides the standing protocol for school 75 epinephrine auto-injectors are not liable for any injury arising 76 from the use of an epinephrine auto-injector administered by 77 trained school personnel who follow the adopted protocol and 78 whose professional opinion is that the student is having an 79 anaphylactic reaction: 80 a. Unless the trained school personnel’s action is willful 81 and wanton; 82 b. Notwithstanding that the parents or guardians of the 83 student to whom the epinephrine is administered have not been 84 provided notice or have not signed a statement acknowledging 85 that the school district is not liable; and 86 c. Regardless of whether authorization has been given by 87 the student’s parents or guardians or by the student’s 88 physician, physician assistant, or advanced practice registered 89 nurse. 90 Section 3. This act shall take effect July 1, 2024.